Surfactant pretreatment decreases long-term damage after ischemia-reperfusion injury of the lung

van der Kaaij, Niels P.; Kluin, Jolanda; Haitsma, Jack J.; den Bakker, Michael A.; Lambrecht, Bart N.; Lachmann, Burkhard; de Bruin, Ron W.F.; Bogers, Ad J.J.C.
February 2009
European Journal of Cardio-Thoracic Surgery;Feb2009, Vol. 35 Issue 2, p304
Academic Journal
Abstract: Objective: Lung ischemia-reperfusion injury (LIRI) is a risk factor for primary acute graft failure following lung transplantation. LIRI hereby contributes to morbidity and mortality after lung transplantation. We have previously shown that surfactant pretreatment ameliorates LIRI up to 1 week after reperfusion. However, the impact of surfactant pretreatment on long-term outcome following LIRI is unknown. Therefore, the objective of this study was to investigate the effect of surfactant pretreatment on long-term outcome following LIRI. Methods: Male Sprague-Dawley rats (n =63) were randomized to receive intratracheally administered porcine surfactant (400mg/kg) or no pretreatment. One hour thereafter, animals underwent 120min of warm ischemia by clamping the bronchus, pulmonary artery and vein of the left lung. A third group was sham-operated; a fourth group served as unoperated controls. Animals were killed on day 30 or 90 after surgery. Arterial oxygenation and lung compliance were determined. Broncho-alveolar lavage fluid (BALf) was collected to assess surfactant function and alveolar protein. Leukocyte infiltration was determined by flowcytometry in BALf, lung tissue and thoracic lymph nodes. Lungs of three animals per group were used for histological assessment. Results: Lung compliance was lower on day 30 and day 90 after LIRI than in sham-operated controls (day 30 V max 6.1±2.1 vs 12.6±1.3, day 90 6.9±3.0 vs 12.1±1.6; C max day 30 0.49±0.17 vs 1.08±0.21, day 90 0.67±0.31 vs 1.11±0.17). Furthermore, the number of CD45RA+-lymphocytes in left lung tissue was decreased on day 90 compared to unoperated animals (230.633±96.770 vs 696.347±202.909) and the number of macrophages elevated in left BALf on day 90. HE slides of LIRI animals were scored as fibroproliferative with moderate atelectasis. Surfactant pretreatment improved lung compliance (V max day 30 11.7±1.8, day 90 11.1±1.2; C max day 30 1.04±0.23, day 90 1.16±0.21) and normalized the number of CD45RA+-lymphocytes (769.555±421.016) in left lung tissue. Furthermore lung architecture on HE slides was on return to normal. However, more CD5+CD4+-lymphocytes on day 30 (754.788±97.269 vs 430.409±109.909) and more macrophages on day 90 (2.144.000±630.633 vs 867.454±383.220) were measured in pretreated lung tissue compared to LIRI animals. Conclusions: Severe LIRI caused extensive pulmonary injury up to 90 days postoperatively. Surfactant pretreatment normalized pulmonary function, but resulted in an increased number of CD5+CD4+-cells and macrophages in lung tissue.


Related Articles

  • Surfactant as salvage therapy in life threatening primary graft dysfunction in lung transplantation. Amital, Anat; Shitrit, David; Raviv, Yael; Saute, Milton; Bakal, Ilana; Medalion, Benjamin; Kramer, Mordechai R. // European Journal of Cardio-Thoracic Surgery;Feb2009, Vol. 35 Issue 2, p299 

    Abstract: Objective: Impaired surfactant activity may contribute to primary graft dysfunction after lung transplantation. We assessed the role of surfactant treatment in lung transplant recipients with severe life threatening primary lung graft dysfunction. Patients and methods: Five patients...

  • Skeletal Muscle Reperfusion Injury: Reversal by Controlled Limb Reperfusion. Ihnken, Kai; Wildhirt, Stephen; Ihnken, Olaf; Hill, Bradley; Meier, Andreas; Zarins, Christopher; Reitz, Bruce // Vascular Surgery;Mar/Apr2001, Vol. 35 Issue 2, p149 

    Examines the use of controlled limb reperfusion for skeletal muscle reperfusion injury in North America. Inhibition of local and systemic reperfusion changes; Modification of reperfusate and circumstances of initial reperfusion; Reduction of elevated enzyme levels; Normalization of acidosis.

  • A Lung and a Larynx.  // Time;2/28/1969, Vol. 93 Issue 9, p62 

    The article describes the complexity involved in the implantation of a new lung in a human body. It says that lung transplant carries a greater risk of failure due to the basic function of the lung to inhale air from outside the body thus exposing to airborne microbes infection. Surgical...

  • Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis. D. R. McIlroy; D. V. Pilcher; G. I. Snell // BJA: The British Journal of Anaesthesia;Apr2009, Vol. 102 Issue 4, p506 

    Background Primary graft dysfunction (PGD) is a predominant cause of early morbidity and mortality after lung transplantation. Although substantial work has been done to understand risk factors for PGD in terms of donor, recipient, and surgical factors, little is understood regarding the...

  • A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure. Girgis, Reda E.; Khaghani, Asghar // Global Cardiology Science & Practice;2016, Vol. 2016 Issue 1, p1 

    Lung transplantation has grown considerably in recent years and its availability has spread to an expanding number of countries worldwide. Importantly, survival has also steadily improved, making this an increasingly viable procedure for patients with end-stage lung disease and limited life...

  • Taurine attenuates lung ischemia-reperfusion injury after lung transplantation in rats. Guler, Leyla; Tavlasoglu, Murat; Yucel, Orhan; Guler, Adem; Sahin, Mehmet; Kurkluoglu, Mustafa; Sirin, Yusuf; Eken, Ayse; Gamsizkan, Mehmet; Dakak, Mehmet; Gurkok, Sedat; Genc, Onur // Journal of Anesthesia;Jun2014, Vol. 28 Issue 3, p347 

    Purpose: Taurine, the major intracellular free amino acid found in high concentrations in mammalian cells, is known to be an endogenous antioxidant and a membrane-stabilizing agent. It was hypothesized that taurine may be effective in reducing ischemia-reperfusion injury after lung...

  • What every pediatrician needs to know about lung transplants in children. Faro, Albert // Contemporary Pediatrics;Aug2000, Vol. 17 Issue 8, p61 

    Discusses indications, contraindications and other aspects concerning lung transplantation in children in the United States (U.S.). Number of pediatric lung and heart-lung transplant performed in the U.S. between 1987 and 1998; Two major types of lung transplant; Categories of immunosuppressants...

  • Extended donor criteria for lung transplantation–a clinical reality. Aigner, Clemens; Winkler, Guenther; Jaksch, Peter; Seebacher, Gernot; Lang, Gyorgy; Taghavi, Sharokh; Wisser, Wilfried; Klepetko, Walter // European Journal of Cardio-Thoracic Surgery;May2005, Vol. 27 Issue 5, p757 

    Abstract: Objective: Standard lung donor criteria have been established on opinions and individual experiences rather than on existing evidence. Since the scarcity of donor organs is one of the major limitations to lung transplantation, extension of donor lung criteria might considerably...

  • Glutathione preconditioning ameliorates mitochondria dysfunction during warm pulmonary ischemia—reperfusion injury†, ‡. Sommer, Sebastian-Patrick; Sommer, Stefanie; Sinha, Bhanu; Walter, Daniel; Aleksic, Ivan; Gohrbandt, Bernhard; Otto, Christoph; Leyh, Rainer G. // European Journal of Cardio-Thoracic Surgery;Jan2012, Vol. 41 Issue 1, p140 

    OBJECTIVES: Reduced glutathione (GSH) has been shown to improve pulmonary graft preservation. Mitochondrial dysfunction is regarded to be the motor of ischemia–reperfusion injury (IR) in solid organs. We have shown previously that IR induces pulmonary mitochondrial damage. This study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics